Last Updated:
Searching
Create account to add to watchlist!
Create account to add to watchlist!

Sanaby Health Acquisition Corp. I - SANB

  • Commons

    $10.13

    +0.00%

    SANB Vol: 0.0

  • Warrants

    $0.06

    +0.00%

    SANBW Vol: 0.0

  • Units

    $10.14

    +0.00%

    SANBU Vol: 0.0

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 0.0
Average Volume: 0.0
52W Range: $0.00 - $0.00
Weekly %: +0.00%
Monthly %: +0.00%
Inst Owners: nan

Info

Target: Searching
Days Since IPO: 615
Unit composition:
Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one-half of one redeemable warrant
Trust Size: 15000000.0M

🕵Stocktwit Mentions

Quantisnow posted at 2022-10-31T20:51:06Z

$SANB 📜 SEC Form 15-12G filed by Sanaby Health Acquisition Corp. I https://quantisnow.com/i/3604279?utm_source=stocktwits 45 seconds delayed.

Newsfilter posted at 2022-10-31T20:50:17Z

$SANB Form 15-12G (securities registration termination [section 12(g)]) filed with the SEC https://newsfilter.io/a/9dda85fd744ac755633206ea781fae45

shortablestocks posted at 2022-10-26T15:12:53Z

Zero shares available to short currently in $SANB. https://shortablestocks.com/?SANB

shortablestocks posted at 2022-10-25T15:12:30Z

Zero shares available to short currently in $SANB. https://shortablestocks.com/?SANB

macroaxis posted at 2022-10-25T01:00:33Z

$SANB - Is Sanaby Health Acquisition outlook positive for November 2022?… https://www.macroaxis.com/predict/SANB/Sanaby-Health-Acquisition #stocks #earnings

shortablestocks posted at 2022-10-24T15:11:20Z

Zero shares available to short currently in $SANB. https://shortablestocks.com/?SANB

Quantisnow posted at 2022-10-20T20:29:19Z

$SANB 📜 SEC Form 25-NSE filed by Sanaby Health Acquisition Corp. I https://quantisnow.com/i/3558819?utm_source=stocktwits 45 seconds delayed.

Newsfilter posted at 2022-10-20T20:28:40Z

$SANB Form 25-NSE (notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities) filed with the SEC https://newsfilter.io/a/d9d8db610367db18e8f2ea4fb54af296

Quantisnow posted at 2022-10-17T21:27:43Z

$SANB 📜 Sanaby Health Acquisition Corp. I filed SEC Form 8-K: Other Events, Financial Statements and Exhibits https://quantisnow.com/i/3540892?utm_source=stocktwits 45 seconds delayed.

Newsfilter posted at 2022-10-17T21:26:53Z

$SANB Form 8-K: On October 17, 2022, Sanaby Health Acquisition Corp. I issued a press release announcing that due to the Company’s inability to consummate an initial business combination within the ti.. https://newsfilter.io/a/8699c5168dc1991363cbc10384c41a22

fla posted at 2022-10-17T21:17:38Z

$SANB [15s. delayed]: Issued Press Release on October 17, 17:15:00: Sanaby Health Acquisition Corp. I Announces Liquidation https://s.flashalert.me/7ldSZ

cctranscripts posted at 2022-10-17T21:17:09Z

Sanaby Health Acquisition Corp. I Announces Liquidation https://conferencecalltranscripts.com/summary/?id=431713&pr=true $SANB

Quantisnow posted at 2022-10-17T21:15:46Z

$SANB 📰 Sanaby Health Acquisition Corp. I Announces Liquidation https://quantisnow.com/i/3540814?utm_source=stocktwits 45 seconds delayed.

Stock_Titan posted at 2022-10-17T21:15:11Z

$SANB Sanaby Health Acquisition Corp. I Announces Liquidation https://www.stocktitan.net/news/SANB/sanaby-health-acquisition-corp-i-announces-74rfmc5k9yaq.html

Newsfilter posted at 2022-10-17T21:15:10Z

$SANB Sanaby Health Acquisition Corp. I Announces Liquidation https://newsfilter.io/a/c0d592721b5d92e36c587aada2198150

Quantisnow posted at 2022-09-27T20:29:38Z

$SANB 📜 SEC Form 10-K filed by Sanaby Health Acquisition Corp. I https://quantisnow.com/i/3460826?utm_source=stocktwits 45 seconds delayed.

Newsfilter posted at 2022-09-27T20:28:49Z

$SANB Form 10-K (annual report [section 13 and 15(d), not s-k item 405]) filed with the SEC https://newsfilter.io/a/571b797af9e073dcc22b1a5b799f360c

mrshort posted at 2022-06-11T02:54:11Z

$SANB Estimated S.I as on 6/9/22 35.45 Percent Missed out on RDBX today? I have been mentioning RDBX since the price was $2.34 in my discord server ( a month ago). I rank the top 80 highly shorted stock based on Short Interest, Average Shorted Price, Short Loss, Cost to Borrow, fundamental rating and analytical rating. Based on the setup I created RDBX is ranked 1 since May 8th. I share this setup ( screenshot with my discord members) and discuss the upcoming catalyst for the highly shorted stocks. Along with this you will get my weekly watchlist, weekly IPOs, news feeds, day trade alerts ( bull & bear) Please see my home page for more information

mrshort posted at 2022-06-10T02:03:26Z

$SANB Estimated S.I as on 6/9/22 35.45 Percent While the Market is down, my Discord Members were still in profits from CSSE and BEEM - from the list I have provide them with highly shorted Stock. I rank the top 80 highly shorted stock based on S.I, Average Shorted Price, Short Loss, Cost to Borrow & some other factors based on the set up I create for likely squeeze or just oversold stock with momentum upwards. You will also get stock alerts on bear market , news, IPO's & value stock analysis. Please see my home page for more information

mrshort posted at 2022-06-09T03:16:56Z

$SANB Estimated S.I as on 6/8/22 35.45 Percent Missed out on TBLT 20% hike today? I gave a this trade alert to my Discord Members at 7:30 AM on 6/8/2022, TBLT was ranked 2 based on the set up created to analyze the highly shorted stock. I rank the top 80 highly shorted stock based on S.I, Average Shorted Price, Short Loss, Cost to Borrow & some other factors based on the set up I create for likely squeeze or just oversold stock with momentum upwards. My discord members will also get stock alerts on bear market , news, IPO's & Value stock analysis. Here is the screen shot from my Discord channel. TBLT kicked up 20% today after 2:00 PM. Visit my home page ( for Discord server link). I was up 52% last 10 days trading RDBX GTLB, GME and SNMP

mrshort posted at 2022-06-08T02:52:29Z

$SANB Estimated S.I as on 6/7/22 35.45 Percent Me and my Discord members made profits from all 4 trades, SNMP , GME, RDBX and GTLB - these stocks where highly shorted, the catalyst, earnings, short loss resulted in the upward moment today. I am specialized in finding opportunities for highly Shorted Stocks and possible Squeeze Stocks with the set up I created over time ( based on past algo's) . I rank the top 80 highly shorted stock based on S.I, Average Shorted Price, Short Loss, Cost to Borrow & some other factors Along with that you will daily stock alerts ( both bull and bear) , News, IPO's & Value Stock Analysis. See the sample screen shot from the Discord channel . Visit my home page to get the link to join.

mrshort posted at 2022-06-07T00:25:05Z

$SANB Estimated S.I as on 6/6/22 35.45 Percent Missed out on VERU, RPTX and RDBX swing trade last week, my discord members didn’t. Combination of high Short Interest, Short loss and Catalyst helped the price upward moment I am specialized in finding opportunities for highly Shorted Stocks and possible Squeeze Stocks with the set up I created over time ( based on past algo's) . I rank the top 80 highly shorted stock based on S.I, Average Shorted Price, Short Loss, Cost to Borrow & some other factors Along with that you will daily stock alerts ( both bull and bear) , News, IPO's & Value Stock Analysis. I was up 42% - with this setup I have created, please visit my home page for more information

mrshort posted at 2022-06-05T20:16:07Z

$SANB Estimated S.I as on 6/3/22 35.45 Percent Missed out on VERU, RPTX and RDBX swing trade last week, my discord members didn’t. Combination of high Short Interest, Short loss and Catalyst helped the price upward moment I am specialized in finding opportunities for highly Shorted Stocks and possible Squeeze Stocks with the set up I created over time ( based on past algo's) . I rank the top 80 highly shorted stock based on S.I, Average Shorted Price, Short Loss, Cost to Borrow & some other factors Along with that you will daily stock alerts ( both bull and bear) , News, IPO's & Value Stock Analysis. I was up 42% - with this setup I have created, please visit my home page for more information

mrshort posted at 2022-06-03T02:04:24Z

$SANB Estimated S.I as on 6/2/22 35.45 Percent Missed out on RDBX run, My Discord members were able to get this trade from the information I provide in the server. I am specialized in finding Short Squeeze Stocks with the set up I created over time ( based on past algo's) . I rank the top 80 highly shorted stock based on S.I, Average Shorted Price, Short Loss, Cost to Borrow & some other factors Along with that you will daily stock alerts ( both bull and bear) , News, IPO's & Value Stock Analysis. I was up 42% - with this setup I have created, please visit my home page for more information

Quantisnow posted at 2022-05-16T20:18:54Z

$SANB 📜 SEC Form 10-Q filed by Sanaby Health Acquisition Corp. I https://quantisnow.com/i/2895896?utm_source=stocktwits 45 seconds delayed.

Newsfilter posted at 2022-05-16T20:18:06Z

$SANB Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC https://newsfilter.io/a/6aa7c3ccafdd162263db4cb3358b8632

cctranscripts posted at 2022-05-06T19:07:01Z

SEC Staff Action: ORDER https://www.conferencecalltranscripts.com/summary/?id=10811226 $SANB

Management

Officers, Directors and Director Nominees,” “Conflicts of Interest” and “Certain Relationships and Related Party Transactions.” Each of our officers and directors presently has, and any of them in the future may have, additional fiduciary or contractual obligations to other entities and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented. Following the completion of this offering and until we consummate our initial business combination, we intend to engage in the business of identifying and combining with one or more businesses. Our directors and officers may now be, or in the future become, affiliated with entities that are engaged in a similar business. In addition, our directors and officers may become aware of business opportunities which may be appropriate for presentation to us and the other entities to which they owe certain fiduciary or contractual duties. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential target business may be presented to other entities prior to its presentation to us, subject to our directors’ and officers’ fiduciary duties under the DGCL. Our amended and restated certificate of incorporation will provide that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of the company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent the director or officer is permitted to refer that opportunity to us without violating another legal obligation. Our sponsor and directors and officers are also not prohibited from sponsoring, investing or otherwise becoming involved with, any other blank check companies similar to ours, including in connection with their initial business combinations, or may pursue other business or investment ventures during the period in which we are seeking an initial business combination. Any such companies, businesses or ventures may present additional conflicts of interest in pursuing an initial business combination. However, we do not believe that any such potential conflicts would materially affect our ability to complete our initial business combination. For further discussion of our executive officers’ and directors’ business affiliations and the potential conflicts of interest that you should be aware of, please see “Officers, Directors and Director Nominees,” “Conflicts of Interest” and “Certain Relationships and Related Party Transactions.” Members of our management team and board of directors have significant experience as founders, board members, officers, executives or employees of other companies. Certain of those persons have been, may be, or may become, involved in litigation, investigations or other proceedings, including related to those companies or otherwise. The defense or prosecution of these matters could be time-consuming and could divert our management’s attention, and may have an adverse effect on us, which may impede our ability to consummate an initial business combination. During the course of their careers, members of our management team and board of directors have had significant experience as founders, board members, officers, executives or employees of other companies. As a result of their involvement and positions in these companies, certain of those persons have been, may be or may in the future become involved in litigation, investigations or other proceedings, including relating to the business affairs of such companies, transactions entered into by such companies, or otherwise. Individual members of our management team and board of directors also may become involved in litigation, investigations or other proceedings involving claims or allegations related to or as a result of their previous personal conduct, either in their capacity as a corporate officer or director or otherwise, and may be personally named in such actions and potentially subject to personal liability as a result of their previous individual conduct or otherwise. Any such liability may or may not be covered by insurance and/or indemnification, depending on the facts and circumstances. The defense or prosecution of these matters could be time-consuming. Any litigation, investigations or other proceedings and the potential outcomes of such actions may divert the attention and resources of our management team and board of directors away from identifying and selecting a target business or businesses for our initial business combination and may negatively affect our reputation, which may impede our ability to complete an initial business combination. 51 Our officers, directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests. We have not adopted a policy that expressly prohibits our directors, officers, security holders or affiliates from having a direct or indirect pecuniary or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may enter into an initial business combination with a target business that is affiliated with our sponsor, our directors, our advisors or officers, although we do not intend to do so. We do not have a policy that expressly prohibits any such persons from engaging for their own account in business activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between their interests and ours. Since our officers and directors will be eligible to share in a portion of any appreciation in founder shares purchased at an original purchase price of approximately $0.005 per share, a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination. The members of our management team have invested in our sponsor by subscribing units issued by the sponsor. These officers and directors will not receive any cash compensation from us prior to a business combination but through their investment in the sponsor will be eligible to share in a portion of any appreciation in founder shares and private placement units, provided that we successfully complete a business combination. We believe that this structure aligns the incentives of these officers and directors with the interests of our stockholders. However, investors should be aware that, as these officers and directors have paid an original purchase price of approximately $0.005 per share for the interest in the founder shares, this structure also creates an incentive whereby our officers and directors could potentially make a substantial profit even if we complete a business combination with a target that ultimately declines in value and is not profitable for public investors. Changes in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination. In recent months, the market for directors and officers liability insurance for special purpose acquisition companies has changed. Fewer insurance companies are offering quotes for directors and officers liability coverage, the premiums charged for such policies have generally increased and the terms of such policies have generally become less favorable. There can be no assurance that these trends will not continue. The increased cost and decreased availability of directors and officers liability insurance could make it more difficult and more expensive for us to negotiate an initial business combination. In order to obtain directors and officers liability insurance or modify its coverage as a result of becoming a public company, the post-business combination entity might need to incur greater expense, accept less favorable terms or both. However, any failure to obtain adequate directors and officers liability insurance could have an adverse impact on the post-business combination’s ability to attract and retain qualified officers and directors. In addition, even after we were to complete an initial business combination, our directors and officers could still be subject to potential liability from claims arising from conduct alleged to have occurred prior to the initial business combination. As a result, in order to protect our directors and officers, the post-business combination entity may need to purchase additional insurance with respect to any such claims (“run-off insurance”). The need for run-off insurance would be an added expense for the post-business combination entity, and could interfere with or frustrate our ability to consummate an initial business combination on terms favorable to our investors. We may engage in an initial business combination with one or more target businesses that have relationships with entities that may be affiliated with our sponsor, officers, directors or existing holders which may raise potential conflicts of interest. In light of the involvement of our sponsor, officers and directors with other entities, we may decide to acquire one or more businesses affiliated with our sponsor, officers, advisors or directors. Our directors also serve as officers and board members for other entities, as well as without limitation, those described under the section of this prospectus entitled “Management — Conflicts of Interest.” Such entities may compete with us for business combination opportunities. Our sponsor, officers and directors are not currently aware of any specific opportunities for us to complete our initial business combination with any entities with which they are affiliated, and there have been no preliminary discussions concerning an initial business combination with any such entity or entities. 52 Although we will not be specifically focusing on, or targeting, any transaction with any affiliated entities, we would pursue such a transaction if we determined that such affiliated entity met our criteria for an initial business combination as set forth in the section of this prospectus entitled “Proposed Business — Selection of a Target Business and Structuring of our Initial Business Combination” and such transaction was approved by a majority of our disinterested directors. Despite our agreement to obtain an opinion from an independent investment banking firm or from another independent entity that commonly renders valuation opinions, regarding the fairness to our stockholders from a financial point of view of an initial business combination with one or more businesses affiliated with our officers, directors or existing holders, potential conflicts of interest still may exist and, as a result, the terms of the initial business combination may not be as advantageous to our public stockholders as they would be absent any conflicts of interest. Our management may not be able to maintain control of a target business after our initial business combination. We may structure an initial business combination so that the post-transaction company in which our public stockholders own shares will own less than 100% of the equity interests or assets of a target business, but we will only complete such business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for us not to be required to register as an investment company under the Investment Company Act. We will not consider any transaction that does not meet such criteria. Even if the post-transaction company owns 50% or more of the voting securities of the target, our stockholders prior to the initial business combination may collectively own a minority interest in the post business combination company, depending on valuations ascribed to the target and us in the initial business combination. For example, we could pursue a transaction in which we issue a substantial number of new shares of Class A common stock in exchange for all of the outstanding capital stock of a target. In this case, we would acquire a 100% interest in the target. However, as a result of the issuance of a substantial number of new shares of common stock, our stockholders immediately prior to such transaction could own less than a majority of our outstanding shares of common stock subsequent to such transaction. In addition, other minority stockholders may subsequently combine their holdings resulting in a single person or group obtaining a larger share of the company’s stock than we initially acquired. Accordingly, this may make it more likely that our management will not be able to maintain our control of the target business. We cannot provide assurance that, upon loss of control of a target business, new management will possess the skills, qualifications or abilities necessary to profitably operate such business. Risks Relating to Our Securities If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our initial business combination. If we are deemed to be an investment company under the Investment Company Act, our activities may be restricted, including: •restrictions on the nature of our investments; and •restrictions on the issuance of securities, each of which may make it difficult for us to complete our initial business combination. In addition, we may have imposed upon us burdensome requirements, including: •registration as an investment company; •adoption of a specific form of corporate structure; and •reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations. 53 In order not to be regulated as an investment company under the Investment Company Act, unless we can qualify for an exclusion, we must ensure that we are engaged primarily in a business other than investing, reinvesting or trading in securities and that our activities do not include investing, reinvesting, owning, holding or trading “investment securities” constituting more than 40% of our total assets (exclusive of U.S. government securities and cash items) on an unconsolidated basis. Our business will be to identify and complete an initial business combination and thereafter to operate the post-transaction business or assets for the long term. We do not plan to buy businesses or assets with a view to resale or profit from their resale. We do not plan to buy unrelated businesses or assets or to be a passive investor. We do not believe that our anticipated principal activities will subject us to the Investment Company Act. To this end, the proceeds held in the trust account may only be invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than on buying and selling businesses in the manner of a merchant bank or private equity fund), we intend to avoid being deemed an “investment company” within the meaning of the Investment Company Act. This offering is not intended for persons who are seeking a return on investments in government securities or investment securities. The trust account is intended as a holding place for funds pending the earliest to occur of: (i) the completion of our initial business combination; (ii) the redemption of any public shares properly submitted in connection with a stockholder vote to amend our amended and restated certificate of incorporation (A) to modify the substance or timing of our obligation to offer redemption rights in connection with any proposed initial business combination or certain amendments to our charter prior thereto or to redeem 100% of our public shares if we do not complete our initial business combination within 12 months, which is extendable at our sponsor’s option to up to 18 months, as described herein, from the closing of this offering or (B) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity; or (iii) absent an initial business combination within 12 months, which is extendable at our sponsor’s option to up to 18 months, as described herein, from the closing of this offering, our return of the funds held in the trust account to our public stockholders as part of our redemption of the public shares. Stockholders who do not exercise their redemption rights in connection with an amendment to our certificate of incorporation would still be able to exercise their redemption rights in connection with a subsequent business combination. If we do not invest the proceeds as discussed above, we may be deemed to be subject to the Investment Company Act. If we were deemed to be subject to the Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which we have not allotted funds and may hinder our ability to complete an initial business combination or may result in our liquidation. If we are unable to complete our initial business combination, our public stockholders may receive only approximately $10.15 per share on the liquidation of our trust account and our warrants will expire worthless. We may issue additional common stock or preferred stock to complete our initial business combination or under an employee incentive plan after completion of our initial business combination. We may also issue shares of Class A common stock upon the conversion of the Class B common stock at a ratio greater than one-to-one at the time of our initial business combination as a result of the anti-dilution provisions contained in our amended and restated certificate of incorporation. Any such issuances would dilute the interest of our stockholders and likely present other risks. Our amended and restated certificate of incorporation authorizes the issuance of up to 100,000,000 shares of Class A common stock, par value $0.0001 per share, 10,000,000 shares of Class B common stock, par value $0.0001 per share, and 1,000,000 shares of preferred stock, par value $0.0001 per share. Immediately after this offering, there will be 85,000,000 and 5,500,000 (assuming, in each case, that the underwriters have not exercised their over-allotment option) authorized but unissued shares of Class A common stock and Class B common stock, respectively, available for issuance, which amount does not take into account the shares of Class A common stock reserved for issuance upon exercise of outstanding warrants or the shares of Class A common stock issuable upon conversion of Class B common stock. Immediately after the consummation of this offering, there will be no shares of preferred stock issued and outstanding. Shares of Class B common stock will automatically convert into shares of our Class A common stock at the time of our initial business combination initially at a one-for-one ratio but subject to adjustment as described herein, including in certain circumsta

Holder Stats

1 0
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN
NaN NaN

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2022-11-15 Prelude Capital Management LLC 53,900 $550,000 0.0% 0 1.042%
2022-11-15 Polar Asset Management Partners Inc. 743,739 $7,530,000 0.1% +48.7% 14.372%
2022-11-14 Shaolin Capital Management LLC 727,790 $7,370,000 0.2% +21.3% 14.064%
2022-11-14 Cubist Systematic Strategies LLC 21,893 $220,000 0.0% 0 0.423%
2022-11-14 Verition Fund Management LLC 368,310 $3,730,000 0.0% +89.8% 7.117%
2022-11-14 Linden Advisors LP 36,558 $370,000 0.0% -94.2% 0.706%
2022-11-14 Eisler Capital UK Ltd. 100,000 $1,010,000 0.1% -64.5% 1.932%
2022-11-14 Hsbc Holdings PLC 667,637 $6,760,000 0.0% 0 12.901%
2022-11-10 Wolverine Asset Management LLC 352,049 $3,560,000 0.0% -0.7% 6.803%
2022-11-10 RPO LLC 131,089 $1,330,000 0.3% 0 2.533%
2022-11-07 Warberg Asset Management LLC 40,000 $410,000 0.1% 0 0.773%
2022-11-02 Landscape Capital Management L.L.C. 42,983 $440,000 0.1% +4.5% 0.831%
2022-10-24 Calamos Advisors LLC 40,000 $410,000 0.0% 0 0.773%
2022-08-19 Walleye Capital LLC 65,237 $660,000 0.0% -4.2% 1.259%
2022-08-18 Goldman Sachs Group Inc. 19,289 $190,000 0.0% -12.9% 0.372%
2022-08-17 Centiva Capital LP 25,151 $250,000 0.0% +5.7% 0.486%
2022-08-16 Centiva Capital LP 25,151 $250,000 0.0% +5.7% 0.486%
2022-08-15 Millennium Management LLC 53,821 $540,000 0.0% +7.6% 1.040%
2022-08-12 Sculptor Capital LP 1,067,022 $10,710,000 0.1% +62.0% 20.599%
2022-08-08 Walleye Capital LLC 65,237 $660,000 0.0% -4.2% 1.261%
2022-08-03 Wolverine Asset Management LLC 354,416 $3,560,000 0.0% +7.1% 6.842%
2022-07-29 Mizuho Markets Americas LLC 840,407 $8,440,000 0.6% 0 16.224%
2022-05-27 Walleye Capital LLC 68,117 $680,000 0.0% -4.6% 1.316%
2022-05-20 Sculptor Capital LP 658,516 $6,590,000 0.0% +61.2% 12.725%
2022-05-18 Nomura Holdings Inc. 350,000 $3,510,000 0.0% 0 6.757%
2022-05-17 Walleye Capital LLC 68,117 $680,000 0.0% -4.6% 1.316%
2022-05-17 Radcliffe Capital Management L.P. 56,301 $560,000 0.0% +181.5% 1.087%
2022-05-16 Goldman Sachs Group Inc. 22,154 $220,000 0.0% 0 0.428%
2022-05-16 Rivernorth Capital Management LLC 49,996 $500,000 0.0% +31.7% 0.966%
2022-05-16 Apollo Management Holdings L.P. 300,296 $3,000,000 0.0% 0 5.803%
2022-05-16 Aristeia Capital LLC 650,000 $6,500,000 0.1% 0 12.560%
2022-05-13 Starboard Value LP 251,700 $2,520,000 0.0% -12.8% 4.859%
2022-05-12 Anson Funds Management LP 100,000 $1,000,000 0.1% 0 1.932%
2022-05-12 Omni Event Management Ltd 711,149 $7,110,000 0.4% 0 13.742%
2022-05-11 Landscape Capital Management L.L.C. 41,000 $410,000 0.1% 0 0.792%
2022-05-11 Highbridge Capital Management LLC 922,275 $9,210,000 0.2% +6.2% 17.822%
2022-05-06 Arena Investors LP 19,572 $200,000 0.1% 0 0.378%
2022-05-04 Wolverine Asset Management LLC 330,875 $3,310,000 0.0% -2.5% 6.388%
2022-03-15 Beryl Capital Management LLC 199,998 $1,990,000 0.1% 0 3.865%
2022-03-03 Walleye Capital LLC 71,365 $710,000 0.0% 0 1.379%
2022-02-16 Oaktree Capital Management LP 350,000 $3,470,000 0.0% 0 6.763%
2022-02-15 Saba Capital Management L.P. 1,184,700 $11,760,000 0.2% 0 22.893%
2022-02-15 Starboard Value LP 288,600 $2,860,000 0.0% 0 5.577%
2022-02-15 Karpus Management Inc. 118,696 $1,180,000 0.0% 0 2.294%
2022-02-15 Davidson Kempner Capital Management LP 400,000 $3,960,000 0.1% 0 7.729%
2022-02-14 Whitebox Advisors LLC 80,000 $790,000 0.0% 0 1.546%
2022-02-14 Eisler Capital UK Ltd. 300,000 $2,980,000 0.1% 0 5.797%
2022-02-14 LMR Partners LLP 200,000 $1,990,000 0.0% 0 3.865%
2022-02-14 Radcliffe Capital Management L.P. 20,000 $200,000 0.0% 0 0.386%
2022-02-14 Taconic Capital Advisors LP 100,000 $990,000 0.0% 0 1.932%
2022-02-14 Fifth Lane Capital LP 40,000 $400,000 0.2% 0 0.773%
2022-02-09 MMCAP International Inc. SPC 350,000 $3,470,000 0.2% 0 6.763%
2022-02-09 Wolverine Asset Management LLC 339,381 $3,370,000 0.0% 0 6.558%

SEC Filings

Form Type Form Description Filing Date Document Link
15-12G 15-12G 2022-10-31 https://www.sec.gov/Archives/edgar/data/1856689/000110465922113008/tm2229331d1_1512g.htm
25-NSE 2022-10-20 https://www.sec.gov/Archives/edgar/data/1856689/000135445722000582/xslF25X02/primary_doc.xml
8-K FORM 8-K 2022-10-17 https://www.sec.gov/Archives/edgar/data/1856689/000110465922109409/tm2228412d1_8k.htm
10-K 10-K 2022-09-27 https://www.sec.gov/Archives/edgar/data/1856689/000141057822002814/sanbu-20220630x10k.htm
10-Q 10-Q 2022-05-16 https://www.sec.gov/Archives/edgar/data/1856689/000141057822001654/sanbu-20220331x10q.htm
SC 13G SC 13G 2022-03-07 https://www.sec.gov/Archives/edgar/data/1856689/000119312522066384/d290660dsc13g.htm
SC 13G SC 13G 2022-02-14 https://www.sec.gov/Archives/edgar/data/1856689/000110465922022460/tm226670-1_sc13g.htm
10-Q 10-Q 2022-02-14 https://www.sec.gov/Archives/edgar/data/1856689/000141057822000137/sanbu-20211231x10q.htm
SC 13G/A SC 13G/A 2022-02-14 https://www.sec.gov/Archives/edgar/data/1856689/000119312522037544/d269266dsc13ga.htm
SC 13G/A SANABY HEALTH ACQUISITION CORP. I 2022-02-03 https://www.sec.gov/Archives/edgar/data/1856689/000090266422000995/p22-0366sc13ga.htm
SC 13G/A 2022-02-02 https://www.sec.gov/Archives/edgar/data/1856689/000184671822000023/SanabyHealth12722.txt
SC 13G SANABY HEALTH ACQUISITION CORP. I 2021-12-23 https://www.sec.gov/Archives/edgar/data/1856689/000090266421005377/p21-2738sc13g.htm
10-Q 10-Q 2021-12-02 https://www.sec.gov/Archives/edgar/data/1856689/000141057821000460/sanbu-20210930x10q.htm
NT 10-Q FORM 12B-25 2021-11-30 https://www.sec.gov/Archives/edgar/data/1856689/000110465921144547/tm2134028d3_nt10q.htm
SC 13G FORM SC 13G 2021-11-12 https://www.sec.gov/Archives/edgar/data/1856689/000106299321010724/formsc13g.htm
8-K FORM 8-K 2021-11-08 https://www.sec.gov/Archives/edgar/data/1856689/000110465921135532/tm2132247-1_8k.htm
8-K FORM 8-K 2021-10-25 https://www.sec.gov/Archives/edgar/data/1856689/000110465921129585/tm2130915d1_8k.htm
SC 13G SC 13G 2021-10-22 https://www.sec.gov/Archives/edgar/data/1856689/000110465921128887/tm2130859d1_sc13g.htm
SC 13G SC 13G 2021-10-22 https://www.sec.gov/Archives/edgar/data/1856689/000119312521304648/d193400dsc13g.htm
8-K FORM 8-K 2021-10-19 https://www.sec.gov/Archives/edgar/data/1856689/000110465921127587/tm2130399d1_8k.htm
3 OWNERSHIP DOCUMENT 2021-10-18 https://www.sec.gov/Archives/edgar/data/1856689/000110465921127295/xslF345X02/tm2130446-4_3seq1.xml
3 OWNERSHIP DOCUMENT 2021-10-18 https://www.sec.gov/Archives/edgar/data/1856689/000110465921127292/xslF345X02/tm2130446-3_3seq1.xml
3 OWNERSHIP DOCUMENT 2021-10-18 https://www.sec.gov/Archives/edgar/data/1856689/000110465921127291/xslF345X02/tm2130446-2_3seq1.xml
3 OWNERSHIP DOCUMENT 2021-10-18 https://www.sec.gov/Archives/edgar/data/1856689/000110465921127289/xslF345X02/tm2130446-1_3seq1.xml
424B4 424B4 2021-10-18 https://www.sec.gov/Archives/edgar/data/1856689/000110465921127085/tm2118075-7_424b4.htm
3 OWNERSHIP DOCUMENT 2021-10-15 https://www.sec.gov/Archives/edgar/data/1856689/000110465921126890/xslF345X02/tm2130170d1_3seq1.xml
3 OWNERSHIP DOCUMENT 2021-10-15 https://www.sec.gov/Archives/edgar/data/1856689/000110465921126847/xslF345X02/tm2130170d2_3seq1.xml
EFFECT 2021-10-14 https://www.sec.gov/Archives/edgar/data/1856689/999999999521003882/xslEFFECTX01/primary_doc.xml
CERT 2021-10-14 https://www.sec.gov/Archives/edgar/data/1856689/000135445721001159/8A_Cert_SANB.pdf
CORRESP 2021-10-13 https://www.sec.gov/Archives/edgar/data/1856689/000110465921125852/filename1.htm
8-A12B FORM 8-A12B 2021-10-13 https://www.sec.gov/Archives/edgar/data/1856689/000110465921125810/tm2129941-1_8a12b.htm
CORRESP 2021-10-13 https://www.sec.gov/Archives/edgar/data/1856689/000110465921125715/filename1.htm
CORRESP 2021-10-07 https://www.sec.gov/Archives/edgar/data/1856689/000110465921124247/filename1.htm
S-1/A S-1/A 2021-10-07 https://www.sec.gov/Archives/edgar/data/1856689/000110465921124243/tm2118075-4_s1a.htm
UPLOAD 2021-10-05 https://www.sec.gov/Archives/edgar/data/1856689/000000000021012104/filename1.pdf
S-1 FORM S-1 2021-09-22 https://www.sec.gov/Archives/edgar/data/1856689/000110465921118384/tm2118075d2_s1.htm
DRS/A 2021-08-09 https://www.sec.gov/Archives/edgar/data/1856689/000110465921101972/filename1.htm
DRS 2021-06-09 https://www.sec.gov/Archives/edgar/data/1856689/000110465921078876/filename1.htm